Improving CAR-T Cell Therapies (Immunotherapy Documentary Part III)

Ғылым және технология

The technologies that enable immunotherapies are playing an increasingly critical role in determining how the immune system of a patient will respond to a specific tumor. As immunotherapies become the standard of care for cancer treatments, previous research-use only technologies like Next Generation Sequencing, RNA-Seq, Multi-Parameter Flow Cytometry, and Imaging Mass Cytometry are now being used in clinical setting. The effectiveness of these tools is vital. In this documentary, Biocompare taps the expertise of key opinion leaders, including Craig Monell, VP of Business Operations, BioLegend, to explore how immunotherapies and their supporting technologies are transforming patient care.

Пікірлер: 9

  • @adamcollins9777
    @adamcollins97772 жыл бұрын

    Great video! I have worked in the CAR-T space and it is indeed a very exciting treatment for cancer.

  • @tooneboone3869
    @tooneboone38693 жыл бұрын

    Great news on the ongoing advances.

  • @rebirthoftragedy8276
    @rebirthoftragedy82763 жыл бұрын

    Excellent contribution

  • @ECason-vw7jw
    @ECason-vw7jw Жыл бұрын

    I can't wait till they start work on CAR-T cell therapy for Lupus.

  • @JoshuaOtiang
    @JoshuaOtiangАй бұрын

    Kindly share the link for part i and ii

  • @ericprince3592
    @ericprince35922 жыл бұрын

    Excellent Pharmacogenomics is the wave of the future.

  • @terrihaydon5757
    @terrihaydon57572 жыл бұрын

    My friend passed away about 4 weeks after her T cell was sent back to Australia and put back in her body. She was told that the T cells couldn't keep up with the bad cells, but the worrying part was, she had a cancer on her back which had not grown for a year and after the therapy, it tripled in size within 2 weeks. She also somehow ended up with an "unknown bug" in her lung which no antibiotics were able to kill, she was told she would be on antibiotics for the rest of her life . It turned to Scepticaemia and she died within about a week of the diagnosis. I truly believe the mRNA technology did more harm to her than good. I do wonder if somehow her T Cell was damaged in transit as it had to come from the U.S.A back to Australia. She passed away 1st Feb this year . She knew the treatment was experimental but figured she had nothing to lose. She had Stage 4 Non Hodgkins Lymphoma.

  • @Theyungcity23

    @Theyungcity23

    2 жыл бұрын

    Yeah I agree with it doing more harm than good. My brother used this therapy and in a matter of weeks he went from being able to play catch in the backyard to not being able to move his hands or walk and being in constant pain. He died a few days ago. I really wish we had just gone with stronger chemo instead.

  • @FilmMavericks

    @FilmMavericks

    Жыл бұрын

    Sorry for your loss. A huge part of the problem is that chemotherapy is used as a precursor to CAR-T which makes it far less effective and can even be damaging. If it is done as a front line (as my wife had for her NHL) it has almost no side effects and can be wonderfully helpful, possibly even a cure. But of course the FDA won’t allow this. So we had to go to Mexico to get it done at the Immunotherapy Institute.

Келесі